Lactobacillus rhamnosus GG inhibits the toxic effects of Staphylococcus aureus on epidermal keratinocytes

Applied and Environmental Microbiology

Volumn 80, Issue 18, 2014, Pages 5773-5781

  Mohammedsaeed, Walaa ^a   McBain, Andrew J ^a   Cruickshank, Sheena M ^a   O'Neill, Catherine A ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BIOTECHNOLOGY; MICROBIOLOGY;

BACTERIAL ADHESION; HUMAN KERATINOCYTES; LACTOBACILLUS RHAMNOSUS; POTENTIAL BENEFITS; PROBIOTIC BACTERIA; PROTECTIVE EFFECTS; STAPHYLOCOCCUS AUREUS; TOPICAL APPLICATION;

BACILLI;

ADHESION; BACTERIUM; FLUID; INCUBATION; SURVIVAL; TOXICITY;

ANTIBIOSIS; BACTERIUM ADHERENCE; CELL CULTURE; CELL SURVIVAL; GROWTH, DEVELOPMENT AND AGING; HUMAN; KERATINOCYTE; LACTOBACILLUS RHAMNOSUS; MICROBIOLOGY; PHYSIOLOGY; STAPHYLOCOCCUS AUREUS;

ANTIBIOSIS; BACTERIAL ADHESION; CELL SURVIVAL; CELLS, CULTURED; HUMANS; KERATINOCYTES; LACTOBACILLUS RHAMNOSUS; STAPHYLOCOCCUS AUREUS;

EID: 84906336178     PISSN: 00992240     EISSN: 10985336     Source Type: Journal    
DOI: 10.1128/AEM.00861-14     Document Type: Article

References (58)

1. Rolfe RD. 2000. The role of probiotic cultures in the control of gastrointestinal health. J. Nutr. 130:396S-402S.
2. Sanders ME. 1999. Probiotics. Food Technol. 53:67-77.
3. Ewaschuk JB, Diaz H, Meddings L, Diederichs B, Dmytrash A, Backer J, Looijer-van Langen M, Madsen KL. 2008. Secreted bioactive factors from Bifidobacterium infantis enhance epithelial cell barrier function. Am. J. Physiol. Gastrointest. Liver Physiol. 295:G1025-G1034. http://dx.doi.org/10.1152/ajpgi.90227.2008.
4. Isolauri E, Sütas Y, Kankaanpää P, Arvilommi H, Salminen S. 2001. Probiotics: effects on immunity. Am. J. Clin. Nutr. 73:444S-450S.
5. Kaila M, Isolauri E, Soppi E, Virtanen E, Laine S, Arvilommi H. 1992. Enhancement of the circulating antibody secreting cell response in human diarrhoea by a human Lactobacillus strain. Pediatr. Res. 32:141-144. http://dx.doi.org/10.1203/00006450-199208000-00002.
6. Lai Y, Cogen AL, Radek KA, Park HJ, Macleod DT, Leichtle A, Ryan AF, Di Nardo A, Gallo RL. 2010. Activation of TLR2 by a small molecule produced by Staphylococcus epidermidis increases antimicrobial defense against bacterial skin infections. J. Invest. Dermatol. 130:2211-2221. http://dx.doi.org/10.1038/jid.2010.123.
7. Di Cagno R, De Angelis M, Calasso M, Vincentini O, Vernocchi P, Ndagijimana M, De Vincenzi M, Dessi MR, Guerzoni ME, Gobbetti M. 2010. Quorum sensing in sourdough Lactobacillus plantarum DC400: induction of plantaricin A (PlnA) under co-cultivation with other lactic acid bacteria and effect of PlnA on bacterial and Caco-2 cells. Proteomics 10: 2175-2190. http://dx.doi.org/10.1002/pmic.200900565.
8. Coconnier MH, Bernet MF, Kerneis S, Chauvière G, Fourniat J, Servin AL. 1993. Inhibition of adhesion of enteroinvasive pathogens to human intestinal Caco-2 cells by Lactobacillus acidophilus strain LB decreases bacterial invasion. FEMS Microbiol. Lett. 110:299-306. http://dx.doi.org/10.1111/j.1574-6968.1993.tb06339.x.
9. Gan Bingâ S, Kim J, Reid G, Cadieux P, Howard JC. 2002. Lactobacillus fermentum RC-14 inhibits Staphylococcus aureus infection of surgical implants in rats. J. Infect. Dis. 185:1369-1372. http://dx.doi.org/10.1086/340126.
10. Collado MC, Isolauri E, Salminen S. 2008. Specific probiotic strains and their combinations counteract adhesion of Enterobacter sakazakii to intestinal mucus. FEMS Microbiol. Lett. 285:58-64. http://dx.doi.org/10.1111/j.1574-6968.2008.01211.x.
11. Mack D, Michail S, Wei S, Mcdougall L, Hollingworth MA. 1999. Probiotics inhibit enteropathogenic E. coli adherence in vitro by inducing intestinal mucin gene expression. Am. J. Physiol. Gastrointest. Liver Physiol. 276:G941-G950.
12. Ohnemus U, Kohrmeyer K, Houdek P, Rohde H, Wladykowski E, Vidal S, Horstkotte MA, Aepfelbacher M, Kirschner N, Behne MJ, Moll I, Ouwehand AC, Kirijavainen PV, Short C, Salminen S. 1999. Probiotics: mechanisms and established effects. Int. Dairy J. 9:43-52. http://dx.doi.org/10.1016/S0958-6946(99)00043-6.
13. Resta-Lenert S, Barrett KE. 2003. Live probiotics protect intestinal epithelial cells from the effects of infection with enteroinvasive Escherichia coli (EIEC). Gut 52:988-997. http://dx.doi.org/10.1136/gut.52.7.988.
14. Sarika AR, Lipton AP, Aishwarya MS. 2010. Bacteriocin production by a new isolate of Lactobacillus rhamnosus GP1 under different culture conditions. Adv. J. Food Sci. Technol. 2:291-297.
15. Iwase T, Uehara Y, Shinji H, Tajima A, Seo H, Takada K, Agata T, Mizunoe Y. 2010. Staphylococcus epidermidis Esp inhibits Staphylococcus aureus biofilm formation and nasal colonization. Nature 465:346-349. http://dx.doi.org/10.1038/nature09074.
16. Mcbain AJ, Madhwani T, Eatough J, Ledder R. 2009. An introduction to probiotics for dental health. Food Sci. Technol. Bull. 6:5-29. http://dx.doi.org/10.1616/1476-2137.15748.
17. Reid G, Beuerman D, Heinemann C, Bruce AW. 2001. Probiotic Lactobacillus dose required to restore and maintain a normal vaginal flora. FEMS Immunol. Med. Microbiol. 32:37-41. http://dx.doi.org/10.1111/j.1574-695X.2001.tb00531.x.
18. Rayes N, Seehofer D, Muller AR, Hansen S, Bengmark S, Neuhaus P. 2002. Influence of probiotics and fibre on the incidence of bacterial infections following major abdominal surgery-results of a prospective trial. Z. Gastroenterol. 40:869-876. (In German.) http://dx.doi.org/10.1055/s-2002-35259.
19. Cinque B, La Torre C, Melchiorre E, Marchesani G, Zoccali G, Palumbo P, Di Marzio L, Masci A, Mosca L, Mastromarino P, Giuliani M, Cifone MG. 2011. Use of probiotics for dermal applications. Microbiol. Monogr. 21:221-241. http://dx.doi.org/10.1007/978-3-642-20838-6_9.
20. Gueniche A, Castiel I. 2009. Probiotic lysate applied to skin: in vitro evidences of beneficial effects of Bifidobacterium longum sp on sensitive skin and aging. J. Invest. Dermatol. 129:S64.
21. Guéniche A, Bastien P, Ovigne JM, Kermici M, Courchay G, Chevalier V, Breton L, Castiel-Higounenc I. 2010. Bifidobacterium longum lysate, a new ingredient for reactive skin. Exp. Dermatol. 19:e1-e8. http://dx.doi.org/10.1111/j.1600-0625.2009.00932.x.
22. Gueniche A, David P, Achachi A, Vocanson M, Buyukpamukcu A, Bastien P, Nicolas JF, Castiel I. 2009. Oral supplementation with Lactobacillus johnsonii reinforces skin immune homeostasis following UV exposure and limits UV-induced damages. J. Invest. Dermatol. 129:S34.
23. Gueniche A, Delattre C, Winstall E, Bastien P, Bernard D, Castiel-Higounec I. 2010. An original topical probiotic related ingredient for dry skin: efficacy evaluated in a clinical trial with the help of bioinstrumental measurements and proteomic tools. J. Invest. Dermatol. 130:S65.
24. Sultana R, Mcbain AJ, O'Neill CA. 2013. Strain-dependent augmentation of tight-junction barrier function in human primary epidermal keratinocytes by Lactobacillus and Bifidobacterium lysates. Appl. Environ. Microbiol. 79:4887-4894. http://dx.doi.org/10.1128/AEM.00982-13.
25. Al-Ghazzewi FH, Tester RF. 2010. Effect of konjac glucomannan hydrolysates and probiotics on the growth of the skin bacterium Propionibacterium acnes in vitro. Int. J. Cosmet. Sci. 32:139-142. http://dx.doi.org/10.1111/j.1468-2494.2009.00555.x.
26. Di Marzio L, Centi C, Cinque B, Masei S, Giuliani M, Arclei A, Zicari L, Simone CD, Cifone MG. 2003. Effect of lactic acid bacterium Streptococcus thermophilus on stratum corneum ceramide levels and signs and symptoms of atopic dermatitis patients. Exp. Dermatol. 12:615-620. http://dx.doi.org/10.1034/j.1600-0625.2003.00051.x.
27. Nasrabadi HM, Ebrahimi TM, Banadaki DS, Kajousangi TM, Zahedi F. 2011. Study of cutaneous wound healing in rats treated with Lactobacillus plantarum on days 1, 3, 7, 14 and 21. Afr. J. Pharm. Pharmacol. 5:2395-2401.
28. Rodrigues KL, Caputo LR, Carvalho JC, Evangelista J, Schneedorf JM. 2005. Antimicrobial and healing activity of kefir and kefiran extract. Int. J. Antimicrob. Agents 25:404-408. http://dx.doi.org/10.1016/j.ijantimicag.2004.09.020.
29. Valdéz JC, Peral MC, Rachid M, Santana M, Perdigon G. 2005. Interference of Lactobacillus plantarum with Pseudomonas aeruginosa in vitro and in infected burns: the potential use of probiotics in wound treatment. Clin. Microbiol. Infect. 11:472-479. http://dx.doi.org/10.1111/j.1469-0691.2005.01142.x.
30. Peral MC, Martinez MA, Valdez JC. 2009. Bacteriotherapy with Lactobacillus plantarum in burns. Int. Wound J. 6:73-81. http://dx.doi.org/10.1111/j.1742-481X.2008.00577.x.
31. Zanger P, Holzer J, Schleucher R, Scherbaum H, Schittek B, Gabrysch S. 2010. Severity of Staphylococcus aureus infection of the skin is associated with inducibility of human beta-defensin 3, but not human beta-defensin Infect. Immun. 78:3112-3117. http://dx.doi.org/10.1128/IAI.00078-10.
32. Zanger P, Holzer J, Schleucher R, Steffen H, Schittek B, Gabrysch S. 2009. Constitutive expression of the antimicrobial peptide RNase 7 is associated with Staphylococcus aureus infection of the skin. J. Infect. Dis. 200:1907-1915. http://dx.doi.org/10.1086/648408.
33. Prince T, Mcbain AJ, O'Neill CA. 2012. Lactobacillus reuteri protects epidermal keratinocytes from Staphylococcus aureus-induced cell death by competitive exclusion. Appl. Environ. Microbiol. 78:5119-5126. http://dx.doi.org/10.1128/AEM.00595-12.
34. Collado M, Meriluoto J, Salminen S. 2008. Adhesion and aggregation properties of probiotic and pathogen strains. Eur. Food Res. Technol. 226:1065-1073. http://dx.doi.org/10.1007/s00217-007-0632-x.
35. Vélez MP, De Keersmaecker SC, Vanderleyden J. 2007. Adherence factors of Lactobacillus in the human gastrointestinal tract. FEMS Microbiol. Lett. 276:140-148. http://dx.doi.org/10.1111/j.1574-6968.2007.00908.x.
36. Vesterlund S, Karp M, Salminen S, Ouwehand AC. 2006. Staphylococcus aureus adheres to human intestinal mucus but can be displaced by certain lactic acid bacteria. Microbiology 152:1819-1826. http://dx.doi.org/10.1099/mic.0.28522-0.
37. Agarwal S, Kulshreshtha P, Bambah Mukku D, Bhatnagar R. 2008. Alpha-enolase binds to human plasminogen on the surface of Bacillus anthracis. Biochim. Biophys. Acta 1784:986-994. http://dx.doi.org/10.1016/j.bbapap.2008.03.017.
38. Aleljung P, Paulsson M, Emödy L, Andersson M, Naidu AS, Wadström T. 1991. Collagen binding by lactobacilli. Curr. Microbiol. 23:33-38. http://dx.doi.org/10.1007/BF02092306.
39. Jeffery CJ. 2003. Moonlighting proteins: old proteins learning new tricks. Trends Genet. 19:415-417. http://dx.doi.org/10.1016/S0168-9525(03) 00167-7.
40. Jeffery CJ. 2003. Multifunctional proteins: examples of gene sharing. Ann. Med. 35:28-35.
41. Jeffery CJ. 2009. Moonlighting proteins-an update. Mol. Biosyst. 5:345-http://dx.doi.org/10.1039/b900658n.
42. Kinoshita H, Uchida H, Kawai Y, Kawasaki T, Wakahara N, Matsuo H, Watanabe M, Kitazawa H, Ohnuma S, Miura K, Horii A, Saito T. 2008. Cell surface Lactobacillus plantarum LA 318 glyceraldehyde-3-phosphate dehydrogenase (GAPDH) adheres to human colonic mucin. J. Appl. Microbiol. 104:1667-1674. http://dx.doi.org/10.1111/j.1365-2672.2007.03679.x.
43. Kinoshita H, Uchida H, Kawai Y, Kitazawa H, Miura K, Shiiba K, Horii A, Saito T. 2007. Quantitative evaluation of adhesion of lactobacilli isolated from human intestinal tissues to human colonic mucin using surface plasmon resonance (BIACORE assay). J. Appl. Microbiol. 102:116-123. http://dx.doi.org/10.1111/j.1365-2672.2006.03061.x.
44. Kinoshita H, Wakahara N, Watanabe M, Kawasaki T, Matsuo H, Kawai Y, Kitazawa H, Ohnuma S, Miura K, Horii A, Saito T. 2008. Cell surface glyceraldehyde-3-phosphate dehydrogenase (GAPDH) of Lactobacillus plantarum LA 318 recognizes human A and B blood group antigens. Res. Microbiol. 159:685-691. http://dx.doi.org/10.1016/j.resmic.2008.07.005.
45. Marco ML, Pavan S, Kleerebezem M. 2006. Towards understanding molecular modes of probiotic action. Curr. Opin. Biotechnol. 17:204-http://dx.doi.org/10.1016/j.copbio.2006.02.005.
46. Morita H, Toh H, Oshima K, Murakami M, Taylor TD, Igimi S, Hattori M. 2009. Complete genome sequence of the probiotic Lactobacillus rhamnosus ATCC 53103. J. Bacteriol. 191:7630-7631. http://dx.doi.org/10.1128/JB.01287-09.
47. Ramiah K, Van Reenen CA, Dicks LMT. 2007. Expression of the mucus adhesion genes Mub and MapA, adhesion-like factor EF-Tu and bacteriocins gene plaA of Lactobacillus plantarum 423, monitored with real-time PCR. Int. J. Food Microbiol. 116:405-409. http://dx.doi.org/10.1016/j.ijfoodmicro.2007.02.011.
48. Villamón E, Villalba V, Nogueras MM, Tomas JM, Gozalbo D, Gil ML. 2003. Glyceraldehyde-3-phosphate dehydrogenase, a glycolytic enzyme present in the periplasm of Aeromonas hydrophila. Antonie Van Leeuwenhoek 84:31-38. http://dx.doi.org/10.1023/A:1024435612550.
49. Winram SB, Lottenberg R. 1996. The plasmin-binding protein plr of group A streptococci is identified as glyceraldehyde-3-phosphate dehydrogenase. Microbiology 142:2311-2320. http://dx.doi.org/10.1099/13500872-142-8-2311.
50. Antikainen J, Anton L, Sillanpää J, Korhonen TK. 2002. Domains in the S-layer protein CbsA of Lactobacillus crispatus involved in adherence to collagens, laminin and lipoteichoic acids and in self-assembly. Mol. Microbiol. 46:381-394. http://dx.doi.org/10.1046/j.1365-2958.2002.03180.x.
51. Castaldo C, Vastano V, Siciliano RA, Candela M, Vici M, Muscariello L, Marasco R, Sacco M. 2009. Surface displaced alfa-enolase of Lactobacillus plantarum is a fibronectin binding protein. Microb. Cell Fact. 8:14. http://dx.doi.org/10.1186/1475-2859-8-14.
52. Kirjavainen PV, Ouwehand AC, Isolauri E, Salminen SJ. 1998. The ability of probiotic bacteria to bind to human intestinal mucus. FEMS Microbiol. Lett. 167:185-189. http://dx.doi.org/10.1111/j.1574-6968.1998.tb13226.x.
53. Ramiah K, van Reenen CA, Dicks LM. 2008. Surface-bound proteins of Lactobacillus plantarum 423 that contribute to adhesion of Caco-2 cells and their role in competitive exclusion and displacement of Clostridium sporogenes and Enterococcus faecalis. Res. Microbiol. 159:470-475. http://dx.doi.org/10.1016/j.resmic.2008.06.002.
54. Kirjavainen PV, Tuomola EM, Crittenden RG, Ouwehand AC, Harty DW, Morris LF, Rautelin H, Playne MJ, Donohue DC, Salminen SJ. 1999. In vitro adhesion and platelet aggregation properties of bacteremiaassociated lactobacilli. Infect. Immun. 67:2653-2655.
55. Lai Y, Di Nardo A, Nakatsuji T, Leichtle A, Yang Y, Cogen AL, Wu Z-R, Hooper LV, Schmidt RR, Von Aulock S, Radek KA, Huang C-M, Ryan AF, Gallo RL. 2009. Commensal bacteria regulate Toll-like receptor 3-dependent inflammation after skin injury. Nat. Med. 15:1377-1382. http://dx.doi.org/10.1038/nm.2062.
56. Todorov SD, Dicks LMT. 2005. Growth parameters influencing the production of Lactobacillus rhamnosus bacteriocins ST461BZ and ST462BZ. Ann. Microbiol. 55:283-289.
57. Axelsson LT, Chung TC, Dobrogosz WJ, Lindgren SE. 1989. Production of a broad spectrum antimicrobial substance by Lactobacillus reuteri. Microb. Ecol. Health Dis. 2:131-136.
58. Flynn S, Van Sinderen D, Thornton GM, Holo H, Nes IF, Collins JK. 2002. Characterization of the genetic locus responsible for the production of ABP-118, a novel bacteriocin produced by the probiotic bacterium Lactobacillus salivarius subsp. salivarius UCC118. Microbiology 148:973-984.